GlassScriptPhysician profile
Alan C Gatz
NPI 1588640825
$815.38
in general payments reported to CMS, 2019-2025
13 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.96 · 2023: $265 · 2024: $381 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $800.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $332.81 | 2023-2025 | Farxiga, Breztri, Airsupra |
| Abbvie INC. | $170.33 | 2023-2025 | |
| Procept Biorobotics Corporation | $67.22 | 2024 | Aquabeam System |
| Exact Sciences Corporation | $35.55 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $34.03 | 2024 | Vaxelis, Gardasil 9, Vaxneuvance |
| Glaxosmithkline, LLC. | $29.93 | 2023-2024 | Trelegy Ellipta, Arexvy |
| Pfizer INC. | $29.90 | 2023-2025 | |
| Indivior INC. | $27.37 | 2025 | Sublocade |
| Abbott Laboratories | $19.65 | 2025 | Freestyle Libre 3 |
| Dexcom, INC. | $19.04 | 2024 | Dexcom G6 Transmitter |
| Braeburn INC. | $18.07 | 2025 | Brixadi |
| Currax Pharmaceuticals LLC | $16.52 | 2024 | Contrave |
| Genentech USA, INC. | $14.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Gatz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.